The mission of the National Institute on Drug Abuse (NIDA) is to lead the Nation in bringing the power of science to bear on drug abuse and addiction.
This charge has two critical components. The first is the strategic support and conduct of research across a broad range of disciplines. The second is ensuring the rapid and effective dissemination and use of the results of that research to significantly improve prevention, treatment and policy as it relates to drug abuse and addiction.
Funding decisions will be based primarily on programmatic priority of the Institute and scientific merit of the application. NIDA continues to give additional consideration to first-time R01 investigators and Early Stage Investigators (by NIH definition).
Information regarding the FY 2012 NIH Fiscal Policy for Grants can be found at:
NIDA has established the following funding policy for FY 2012:
NIDA may reduce competing awards from IRG recommended levels in order to increase the number of awards issued. Consistent with NIH funding policy, NIDA will implement a 2% increase at all stipend levels for NRSA awards.
Consistent with overall NIH policy every effort will be made to keep the average size of awards constant at FY 2011 levels or lower.
NIDA will continue to support the: